Global Longlife Hospital and Research Limited has scheduled its 15th Annual General Meeting (AGM) for June 25, 2026, through video conferencing, to seek shareholder approval for a significant change in corporate identity and leadership. The meeting will consider a special resolution to change the company's name to Kanzi Enterprise Limited, Asahi Enterprise Limited, or Siddhaa Enterprise Limited, subject to regulatory approvals. This proposed change aims to reflect the company's diversification and repositioning of business activities away from its current healthcare focus.

The Board of Directors, based on the recommendation of the nomination and remuneration committee, has approved the re-appointment of Mr. Dhruv Jani as Managing Director for a five-year term effective from September 10, 2026, to September 09, 2031. Mr. Jani, who serves as the Promoter and Managing Director, has held the position since September 10, 2021. His re-appointment is subject to shareholder approval and includes a remuneration package of up to ₹36,00,000 per annum. The meeting will also consider the re-appointment of Mr. Manasvi Manu Thapar as an Independent Director for a second term of five years and the appointment of Mr. Hiren Mandaliya as an Independent Director.

Business Diversification and Alteration of Objects

To align with its future growth plans, the company proposes to alter its object clause to include the manufacturing and trading of food products, spices, agricultural produce, and textiles. The new objectives encompass dealing in commodities such as edible oils, cotton, and garments, as well as trading in bullion and precious metals. This strategic shift requires shareholder approval via special resolution and subsequent amendments to the Memorandum of Association.

The Board believes the new name and diversified business activities will better represent the company's growth strategy. The change will not affect the rights or obligations of the shareholders or the company's constitution. The financial performance for the year ended March 31, 2026, showed a gross turnover of ₹0.52 lakh and a net loss of ₹171.95 lakh, with a net worth of ₹2374.93 lakh.

Key Meeting Details

The regulatory filing was made to BSE Limited under Regulation 30 and 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ms. Sucheta Jani, a Non-Executive Director, is disclosed as the wife of Mr. Dhruv Jani. The notice is available on the company's website.

Global Longlife Hospital and Research Limited has approved the re-appointment of Mr. Manasvi Manu Thapar as Independent Director for a second term of five years, subject to shareholder approval. The decision was taken during a Board meeting held on May 30, 2026. The new term is scheduled to commence on September 10, 2026, and will conclude on September 09, 2031.

The Board's decision follows the recommendation of the nomination and remuneration committee. The re-appointment is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has disclosed that Mr. Thapar is not related to any other director on the Board and is not debarred from holding the position of director by any SEBI order.

Mr. Manasvi Manu Thapar holds a B.A. L.L.B (Hons.) degree, a five-year integrated programme from Nirma University in Ahmedabad. He currently runs his own professional practice under the name Candour Legal and brings 10 years of experience to the role.

Details of Appointment